Sildenafil and Drugmakers: A Risky Investment ?

The enduring success of sildenafil has undeniably transformed the healthcare landscape. However, wagering in companies heavily dependent on copycat drugs and the diminishing patent rights surrounding this flagship medication presents a considerable degree of peril . While major pharma firms can s

read more